These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22584791)

  • 1. Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease.
    Uchino M; Ikeuchi H; Matsuoka H; Bando T; Takahashi Y; Takesue Y; Matsumoto T; Tomita N
    Digestion; 2012; 85(4):295-301. PubMed ID: 22584791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up.
    Saracino A; Kelly R; Liew D; Chong A
    Australas J Dermatol; 2011 Aug; 52(3):218-21. PubMed ID: 21834821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.
    Khurrum Baig M; Marquez H; Nogueras JJ; Weiss EG; Wexner SD
    Colorectal Dis; 2004 Jul; 6(4):250-3. PubMed ID: 15206967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoderma gangrenosum in inflammatory bowel disease: the experience at Mater Health Services' Adult Hospital 1998-2009.
    Polcz M; Gu J; Florin T
    J Crohns Colitis; 2011 Apr; 5(2):148-51. PubMed ID: 21453884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of peristomal pyoderma gangrenosum.
    Poritz LS; Lebo MA; Bobb AD; Ardell CM; Koltun WA
    J Am Coll Surg; 2008 Feb; 206(2):311-5. PubMed ID: 18222385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
    Funayama Y; Kumagai E; Takahashi K; Fukushima K; Sasaki I
    Dis Colon Rectum; 2009 Feb; 52(2):311-4. PubMed ID: 19279428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of peristomal pyoderma gangrenosum.
    Kiran RP; O'Brien-Ermlich B; Achkar JP; Fazio VW; Delaney CP
    Dis Colon Rectum; 2005 Jul; 48(7):1397-403. PubMed ID: 15868233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical tacrolimus for parastomal pyoderma gangrenosum: a report of two cases.
    Altieri M; Vaziri K; Orkin BA
    Ostomy Wound Manage; 2010 Sep; 56(9):56-9. PubMed ID: 20855912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
    Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
    Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review.
    Afifi L; Sanchez IM; Wallace MM; Braswell SF; Ortega-Loayza AG; Shinkai K
    J Am Acad Dermatol; 2018 Jun; 78(6):1195-1204.e1. PubMed ID: 29288099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
    Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
    Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
    Carp JM; Onuma E; Das K; Gottlieb AB
    Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyoderma gangrenosum--case report.
    Abela CB; Soldin M; Gateley D
    Br J Oral Maxillofac Surg; 2007 Jun; 45(4):328-30. PubMed ID: 16360244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyoderma gangrenosum: study of 21 patients and proposal of a 'clinicotherapeutic' classification.
    Marzano AV; Trevisan V; Lazzari R; Crosti C
    J Dermatolog Treat; 2011 Oct; 22(5):254-60. PubMed ID: 20666672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peristomal pyoderma gangrenosum and inflammatory bowel disease.
    Cairns BA; Herbst CA; Sartor BR; Briggaman RA; Koruda MJ
    Arch Surg; 1994 Jul; 129(7):769-72. PubMed ID: 7912923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peristomal pyoderma gangrenosum after colectomy for Crohn disease. Successful medical treatment].
    Goudet P; Pillon D; Bensa F; Collet E; Cougard P; Viard H
    Ann Chir; 1992; 46(6):525-9. PubMed ID: 1444154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
    Menachem Y; Gotsman I
    Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peristomal pyoderma gangrenosum: 12-year experience in a single tertiary referral centre.
    Toh JWT; Young CJ; Rickard MJFX; Keshava A; Stewart P; Whiteley I
    ANZ J Surg; 2018 Oct; 88(10):E693-E697. PubMed ID: 29984478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.